Papillary thyroid microcarcinoma: characteristics at presentation, and evaluation of clinical and histological features associated with a worse prognosis in a Latin American cohort

Domínguez, José M; Nilo, Flavia; Martínez, María T; Massardo, José M; Muñoz, Sueli; Contreras, Tania; Carmona, Rocío; Jerez, Joaquín; González, Hernán; Droppelmann, Nicolás; León, Augusto.
Arch. endocrinol. metab. (Online) ; 62(1): 6-13, Jan.-Feb. 2018. tab
Artículo en Inglés | LILACS | ID: biblio-887624

Documentos relacionados

  1. Is Postoperative Adjuvant Radioactive Iodine Ablation Therapy Always Necessary for Intermediate-Risk Papillary Thyroid Cancer Patients With Central Neck Metastasis?
  2. Clinical impact of radioactive iodine dose selection based on the number of metastatic lymph nodes in patients with papillary thyroid carcinoma: A multicenter retrospective cohort study.
  3. Impact of radioiodine therapy on recurrence and survival outcomes in intermediate-risk papillary thyroid carcinoma -A systematic review and meta-analysis.
  4. Thyroidectomy without Radioiodine in Low-Risk Thyroid Cancer.
  5. Thyroidectomy without Radioiodine in Low-Risk Thyroid Cancer.
  6. Thyroidectomy without Radioiodine in Low-Risk Thyroid Cancer.
  7. Thyroidectomy without Radioiodine in Low-Risk Thyroid Cancer. Reply.
  8. Factors Affecting Ablation Success After I-131 Radioactive Iodine Therapy in Low and Intermediate Risk Papillary Thyroid Cancer.
  9. [Comparison of Quality of Life of Patients with Papillary Thyroid Microcarcinoma Treated by Different Modalities].
  10. Papillary Thyroid Carcinoma (PTC) in Children and Adults: Comparison of Initial Presentation and Long-Term Postoperative Outcome in 4432 Patients Consecutively Treated at the Mayo Clinic During Eight Decades (1936-2015).